Loading...

Alpha Teknova, Inc.

TKNONASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.18
$0.010(0.19%)

Alpha Teknova, Inc. (TKNO) Company Profile & Overview

Explore Alpha Teknova, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Alpha Teknova, Inc. (TKNO) Company Profile & Overview

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOStephen Gunstream

Contact Information

831 637 1100
2290 Bert Drive, Hollister, CA, 95023

Company Facts

173 Employees
IPO DateJun 25, 2021
CountryUS
Actively Trading

Frequently Asked Questions

;